secwatch.observer — SEC 8-K summary
======================================

Issuer:     TriSalus Life Sciences, Inc. (TLSI)
CIK:        0001826667
Form:       8-K
Filed at:   2022-12-08T23:59:59+00:00
Accession:  0001104659-22-125257
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MedTech Acquisition adjourns special meeting to Dec 12 to seek votes for extension to June 2023
--------------------------------------------------------------------------------

- Special Meeting adjourned from Dec 7 to Dec 12, 2022 to solicit more votes for Extension Amendment.
- Extension Amendment would push business combination deadline from Dec 22, 2022 to June 22, 2023.
- Adjournment Proposal approved: 18,357,148 FOR, 4,839,932 AGAINST, 56,835 abstain.
- Company is pursuing merger with TriSalus Life Sciences as previously announced on Nov 11, 2022.
- Record date remains Oct 24, 2022; shareholders who already voted need not take action.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826667/000110465922125257/0001104659-22-125257-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826667/000110465922125257/tm2232243d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-125257

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer